Caremark closes its FTC case, Optum Rx is the last holdout
Plus: Omnicare's bankruptcy court hearing is 11 days out. The day's rules, money, and enforcement, sourced and tiered below.
Plus: Omnicare's bankruptcy court hearing is 11 days out. The day's rules, money, and enforcement, sourced and tiered below.
|
American Health Intel
Rules · Money · Medicine · Decoded daily
|
| The Service Line |
Saturday, August 1, 2026 |
|
|
Caremark closes its FTC case, Optum Rx is the last holdout
|
|
Plus: Omnicare's bankruptcy court hearing is 11 days out. The day's rules, money, and enforcement, sourced and tiered below.
|
|
|
Enforcement Confidence: High
The Federal Trade Commission's three year fight with the Big Three pharmacy middlemen, called PBMs, over insulin pricing is down to one holdout after CVS's Caremark closed its case.
Caremark's July 14 settlement delinks its pay from insulin's list price and could save patients up to 8.5B over 10 years. Optum Rx has a proposed deal pending, no final order yet.
|
Why it matters
This closes one of the biggest PBM antitrust cases in years and signals that low cost insulin access terms are becoming standard practice at major pharmacy benefit managers. Watch whether Optum Rx follows with a final order.
|
|
|
Enforcement Confidence: High
CVS Health's long term care pharmacy unit, the company that fills prescriptions for nursing home residents nationwide, is 11 days from a bankruptcy court hearing that closes out its fraud case.
The 440M settlement resolves claims Omnicare dispensed 3.3M prescriptions without valid orders. The underlying 250M sale to GenieRx is already approved, no objections filed.
|
Why it matters
This is the closing chapter of a decade old fraud case that tests how the government prices and prosecutes dispensing without a valid prescription claims in long term care pharmacy. Watch the August 12 hearing for final court approval.
|
|
|
Also today
Warburg Pincus names the PANTHERx Rare deal structure Read
FDA's GLP-1 compounding comment window closes Read
96.5% of independent pharmacists say Part D threatens survival Read
|
354 Records | $28.6B Enforcement | 17 Deadlines | 105 Rules |
|
|
Pick your field on the site and every story tells you what it means for you.
|
|
Reply to this email and tell us what you want covered. We read everything.
|
|
We show our work. We score our own calls.
News and analysis, not legal, medical, coding, or investment advice.
You subscribed at americanhealthintel.com · Unsubscribe
|
|